Increased serum levels of vascular endothelial growth factor predict risk of progression in early B‐cell chronic lymphocytic leukaemia
Open Access
- 24 December 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (3) , 605-610
- https://doi.org/10.1046/j.1365-2141.1999.01752.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 27 references indexed in Scilit:
- Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patientsStrahlentherapie und Onkologie, 1999
- Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β2‐microglobulin in B‐cell chronic lymphocytic leukemiaEuropean Journal of Haematology, 1999
- Chlorambucil in Indolent Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1998
- Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancerAnnals of Oncology, 1996
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumoursThe Lancet, 1994
- Natural history of stage A chronic lymphocytic leukaemia untreated patientsBritish Journal of Haematology, 1990
- Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significanceBritish Journal of Haematology, 1986
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984